Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections

Clinical trial NCT02753946 · COMPLETED

Trial details

NCT number: NCT02753946
Sponsor: Nabriva Therapeutics AG
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Urinary Tract Infection Symptomatic Acute Pyelonephritis Urinary Tract Infection Complicated

Start date: 2016-04-01
Primary completion: 2017-01-12
Enrollment: 465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.